U F Power
Overview
Explore the profile of U F Power including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leemans A, De Schryver M, Van der Gucht W, Heykers A, Pintelon I, Hotard A, et al.
J Virol
. 2017 May;
91(14).
PMID: 28468888
Respiratory syncytial virus (RSV) infections remain a major cause of respiratory disease and hospitalizations among infants. Infection recurs frequently and establishes a weak and short-lived immunity. To date, RSV immunoprophylaxis...
2.
Loulergue P, Burgel P, Carrat F, Fritzell B, Guthmann J, Locht C, et al.
Vaccine
. 2010 Aug;
28(40):6551-5.
PMID: 20674881
The 2nd French Clinical Vaccinology conference held on 20th April 2009 in Paris (France) was a unique opportunity to discuss basic and translational research in vaccinology and its implications for...
3.
Sugawara M, CZAPLICKI J, Ferrage J, Power U, Corvaia N, Nguyen T, et al.
J Pept Res
. 2002 Oct;
60(5):271-82.
PMID: 12383117
BBG2Na is a recombinant protein, composed in part of carrier protein BB and of the central conserved domain of the attachment glycoprotein G of human respiratory syncytial virus (HRSV) subgroup...
4.
Power U, Nguyen T, Rietveld E, de Swart R, Groen J, Osterhaus A, et al.
J Infect Dis
. 2001 Dec;
184(11):1456-60.
PMID: 11709789
A novel recombinant respiratory syncytial virus (RSV) subunit vaccine, designated BBG2Na, was administered to 108 healthy adults randomly assigned to receive 10, 100, or 300 microg of BBG2Na in aluminum...
5.
Power U, Huss T, Michaud V, Bonnefoy J, Nguyen T
J Virol
. 2001 Nov;
75(24):12421-30.
PMID: 11711632
A BALB/c mouse model of enhanced pulmonary pathology following vaccination with formalin-inactivated alum-adsorbed respiratory syncytial virus (FI-RSV) and live RSV challenge was used to determine the type and kinetics of...
6.
Dagouassat N, Robillard V, Haeuw J, Power U, Corvaia N, Nguyen T, et al.
Vaccine
. 2001 Jul;
19(30):4143-52.
PMID: 11457539
Human respiratory syncytial virus (hRSV) is a major pathogen responsible for bronchiolitis and severe pulmonary disease in very young children, immunodeficient patients and the elderly. BBG2Na, a recombinant chimeric protein...
7.
Power U, Goetsch L, Champion T, Beck A, Haeuw J, Nguyen T, et al.
Vaccine
. 2001 Mar;
19(17-19):2345-51.
PMID: 11257359
Respiratory syncytial virus (RSV) is an important respiratory pathogen in man, against which no vaccine is available. However, recent evidence suggests that antibodies to the RSV F and G proteins...
8.
Andersson C, Liljestrom P, Stahl S, Power U
FEMS Immunol Med Microbiol
. 2000 Dec;
29(4):247-53.
PMID: 11118904
Plasmid vectors encoding two different variants, one cytoplasmic and one secreted version, of a candidate vaccine BBG2Na to respiratory syncytial virus (RSV), were constructed and evaluated in a nucleic acid...
9.
Goetsch L, Champion T, Beck A, Corvaia N, Stahl S, Bonnefoy J, et al.
Vaccine
. 2000 Apr;
18(24):2735-42.
PMID: 10781861
The immunogenicity and protective efficacy of BBG2Na, a novel recombinant respiratory syncytial virus subunit vaccine candidate, was assessed in BALB/c mice under various conditions of dose, administration route and number...
10.
Robert A, Chevalet L, Haeuw J, Beck A, Bonnefoy J, Brandt C, et al.
J Virol
. 2000 Mar;
74(8):3455-63.
PMID: 10729118
We analyzed the protective mechanisms induced against respiratory syncytial virus subgroup A (RSV-A) infection in the lower and upper respiratory tracts (LRT and URT) of BALB/c mice after intraperitoneal immunization...